Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses

Behavioural Pharmacology

Volumn 17, Issue 3, 2006, Pages 213-222

  Amitai, Nurith ^b   Liu, Jian ^b,c   Schulteis, Gery ^a,b,c,d  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Addiction; Classical conditioning; Dependence; Morphine; Naloxone; Opioid; Rat; Withdrawal

Indexed keywords

MORPHINE; NALOXONE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; AUDITORY STIMULATION; CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; EXPOSURE; FOOD INTAKE; INJECTION; INSTRUMENTAL CONDITIONING; MALE; MORPHINE ADDICTION; NONHUMAN; PHOTOSTIMULATION; RAT; REWARD; TIME; TRAINING; WITHDRAWAL SYNDROME;

ACOUSTIC STIMULATION; ANIMALS; CONDITIONING, CLASSICAL; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; MALE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; PHOTIC STIMULATION; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33645717460     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200605000-00002     Document Type: Article

References (50)

1. Adams JU, Holtzman SG (1990). Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J Pharmacol Exp Ther 253:483-489.
2. Anagnostaras SG, Gale GD, Fanselow MS (2001). Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus 11:8-17.
3. Anderson MI, Jeffery KJ (2003). Heterogeneous modulation of place cell firing by changes in context. J Neurosci 23:8827-8835.
4. Azar MR, Jones BC, Schulteis G (2003). Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology (Berlin) 170:42-50.
5. Azorlosa JL, Stitzer ML, Greenwald MK (1994). Opioid physical dependence development: effect of single versus repeated morphine pretreatments and of subjects' opioid exposure history. Psychopharmacology (Berlin) 114:71-80.
6. Baldwin HA, Koob GF (1993). Rapid induction of conditioned opiate withdrawal in the rat. Neuropsychopharmacology 8:15-21.
7. Bickel WK, Stitzer ML, Liebson IA, Bigelow GE (1988). Acute physical dependence in man: effects of naloxone after brief morphine exposure. J Pharmacol Exp Ther 244:126-132.
8. Blasig J, Herz A (1977). Precipitated morphine withdrawal as a tool in opiate research. Curr Dev Psychopharmacol 4:129-149.
9. Blasig J, Herz A, Reinhold K, Zieglgansberger S (1973). Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19-38.
10. Childress AR, McLellan AT, Natale M, O'Brien CP (1987). Mood states can elicit conditioned withdrawal and craving in opiate abuse patients. NIDA Res Monogr 76:137-144.
11. Childress AR, Ehrman R, McLellan AT, MacRae J, Natale M, O'Brien CP (1994). Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat 11:17-23.
12. Easterling KW, Holtzman SG (1997). Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists. J Pharmacol Exp Ther 281:188-199.
13. Easterling KW, Holtzman SG (2004). In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation. Psychopharmacology (Berlin) 175:287-295.
14. Everitt BJ, Dickinson A, Robbins TW (2001). The neuropsychological basis of addictive behaviour. Brain Res Rev 36:129-138.
15. Gellert VF, Holtzman SG (1978). Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 205:536-546.
16. Goldberg SR, Schuster CR (1967). Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. J Exp Anal Behav 10:235-242.
17. Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA (1989a). Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I. J Pharmacol Exp Ther 250:485-491.
18. Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA (1989b). Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure. J Pharmacol Exp Ther 248:127-134.
19. Jones R (1980). Dependence in non-addict humans after a single dose of morphine. In: Way E, editor. Endogenous and exogenous opiate agonists and antagonists. New York: Pergamon Press. pp. 557-560.
20. Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129.
21. Linseman MA (1977). Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval. Psychopharmacology (Berlin) 54:159-164.
22. Liu J, Schulteis G (2004). Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Pharmacol Biochem Behav 79:101-108.
23. Martin WR, Eades CG (1964). A comparison between acute and chronic physical dependence in the chronic spinal dog. J Pharmacol Exp Ther 146:385-394.
24. Martin WR, Wikler A, Eades CG, Pescor FT (1963). Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4:247-260.
25. McDonald RV, Siegel S (2004). Intra-administration associations and withdrawal symptoms: morphine-elicited morphine withdrawal. Exp Clin Psychopharmacol 12:3-11.
26. Meyer DR, Sparber SB (1977). Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine. Life Sci 21:1087-1094.
27. Moser EI, Paulsen O (2001). New excitement in cognitive space: between place cells and spatial memory. Curr Opin Neurobiol 11:745-751.
28. O'Brien CP (1996.) Drug addiction and drug abuse. In: Hardman J, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th edition. New York: McGraw-Hill. pp. 557-577.
29. O'Brien CP, Testa T, O'Brien TJ, Greenstein R (1976). Conditioning in human opiate addicts. Pavlov J Biol Sci 11:195-202.
30. Parker LA, Joshi A (1998). Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine. Pharmacol Biochem Behav 61:331-333.
31. Schulteis G, Koob GF (1996). Reinforcement processes in opiate addiction: a homeostatic model. Neurochem Res 21:1437-1454.
32. Schulteis G, Heyser CJ, Koob GF (1997). Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure. Psychopharmacology (Berlin) 129:56-65.
33. Schulteis G, Heyser CJ, Koob GF (1999). Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence. Behav Pharmacol 10:235-242.
34. Schulteis G, Ahmed SH, Morse AC, Koob GF, Everitt BJ (2000). Conditioning and opiate withdrawal. Nature 405:1013-1014.
35. Schulteis G, Markou A, Gold LH, Stinus L, Koob GF (1994). Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271: 1391-1398.
36. Schulteis G, Morse AC, Liu J (2003). Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence. Pharmacol Biochem Behav 76:493-503.
37. Schulteis G, Morse AC, Liu J (2004). Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence. Psychopharmacology (Berlin) 175:463-472.
38. Schulteis G, Liu J, Amitai N, Tzeng S (2005). Context- and cue-conditioned potentiation of acute morphine dependence and withdrawal. Pharmacol Biochem Behav 82:82-89.
39. Sharp PE (1999). Complimentary roles for hippocampal versus subicular/entorhinal place cells in coding place, context, and events. Hippocampus 9:432-443.
40. Siegel S (1976). Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model. Science 193:323-325.
41. Siegel S (1984). Pavlovian conditioning and heroin overdose: reports by overdose victims. Bull Psychonomic Soc 22:428-430.
42. Siegel S, Ellsworth DW (1986). Pavlovian conditioning and death from apparent overdose of medically prescribed morphine: a case report. Bull Psychonomic Soc 24:278-280.
43. Siegel S, Hinson RE, Krank MD, McCully J (1982). Heroin 'overdose' death: contribution of drug-associated environmental cues. Science 216:436-437.
44. Sokolowska M, Siegel S, Kim JA (2002). Intraadministration associations: conditional hyperalgesia elicited by morphine onset cues. J Exp Psychol Anim Behav Process 28:309-320.
45. Way EL, Loh HH, Shen FH (1969). Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167:1-8.
46. Wei E, Loh HH, Way EL (1973). Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther 184:398-403.
47. Wikler A (1971). Some implications of conditioning theory for problems of drug abuse. Behav Sci 16:92-97.
48. Wikler A (1973). Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry 28:611-616.
49. Wikler A, Pescor FT (1967). Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and 'relapse' in morphine-addicted rats. Psychopharmacologia 10:255-284.
50. Young AM (1986). Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone. Psychopharmacology (Berlin) 88: 201-208.